| Document Date: 2012-12-14 16:14:59
Open Document File Size: 211,31 KBShare Result on Facebook
City Philadelphia / Washington / D.C. / Carlsbad / London / New York / / Company Martin Dunitz Ltd / Janssen Pharmaceutica L.P. / Cambridge University Press / HYSICIANSJ P OSTGRADUATE PRESS / PHYSICIANS POSTGRADUATE PRESS INC. / / Country United Kingdom / / Facility Arch Gen Psychiatry / Neuroscience Education Institute / / IndustryTerm treatment of schizophrenia and schizoaffective and schizophreniform disorders / pharmaceutical agents / / MedicalCondition schizophrenia / cognitive symptoms / Seeman P. Does fast dissociation / galactorrhea / hallucinations / fast dissociation / rapid dissociation / movement disorders / Dopamine deficiency / Parkinson’s disease / schizophreniform disorders / dystonia / Visual Hallucinations / faster dissociation / tardive dyskinesia / chronic schizophrenia / paranoia / hyperprolactinemia / akathisia / / Organization Cambridge University / U.S. Food and Drug Administration / Neuroscience Education Institute / / Person Stephen M. Stahl / / Position author / Corresponding author / / Product Permitil / olanzapine / Loxitane / Conventional Antipsychotic / clozapine / Orap / Fluphenazine / Trilafon / Haloperidol / Navane / Serentil / Risperdal / Psychosis Antipsychotic / loxapine / Stelazine / Thiothixene / Sonazine / Droperidol / Atypical Antipsychotic / Seroquel / Seeman P. Antipsychotic / Haldol / risperidone / Geodon / Abilify / Perphenazine / Inapsine / Thorazine / All / Serotonin Atypical / Prolixin / Zyprexa / Clozaril / / ProvinceOrState California / / PublishedMedium Lippincott Williams & Wilkins / / Technology Neuroscience / tomography / PKI / /
SocialTag |
Describing an Atypical Antipsychotic Describing an Atypical Antipsychotic: